Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?
A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding...
Κύριοι συγγραφείς: | Stark, HL, Wang, HC, Kuburic, J, Alzhrani, A, Hester, J, Issa, F |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Frontiers Media
2021
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
ανά: Helen L. Stark, κ.ά.
Έκδοση: (2021-03-01) -
An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring
ανά: Alzhrani, AI
Έκδοση: (2021) -
Biomarkers and surrogates of acute rejection in vascularized composite allograft transplantation
ανά: Honeyman, C, κ.ά.
Έκδοση: (2021) -
Biomarker and surrogate development in vascularised composite allograft transplantation: current progress and future challenges
ανά: Honeyman, C, κ.ά.
Έκδοση: (2020) -
Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
ανά: Maja-Theresa Dieterlen, κ.ά.
Έκδοση: (2021-08-01)